What is the recommended dose of oral semaglutide (Rybelsus) for glucose improvement?

The recommended doses of oral semaglutide (Rybelsus) for improving glucose control are indeed 7 mg or 14 mg. This medication is typically initiated at a lower dose of 3 mg, which is then increased to 7 mg after 30 days. If further glucose improvement is needed, the dose may be escalated to 14 mg. This dosing regimen helps to minimize gastrointestinal side effects and allows the body to adjust to the medication before taking a higher dose. Therefore, both 7 mg and 14 mg are considered therapeutic options for effectively managing blood glucose levels in patients with type 2 diabetes.

In contrast, the other doses listed are not part of the recommended titration schema for oral semaglutide in diabetes management. The 3 mg dose is primarily used as an initiation dose rather than a therapeutic long-term option, while doses of 10 mg and 20 mg are not standard recommendations for this specific medication. Thus, the choice of 7 mg or 14 mg represents the appropriate therapeutic range for glucose improvement with oral semaglutide.